Company Profiles

driven by the PitchBook Platform

Metabolon

Description

Developer of metabolics-based diagnostic testing and research services. The company is the developer of a biochemical biomarker discovery and profiling platform with a pipeline of laboratory-developed tests for obesity-related conditions and cancer.

2000

Founded

PRIVATE

Status

51-200

Employees

Series E3

Latest Deal Type

$30M

Latest Deal Amount

$96M

Total Amount Raised

Description

Developer of metabolics-based diagnostic testing and research services. The company is the developer of a biochemical biomarker discovery and profiling platform with a pipeline of laboratory-developed tests for obesity-related conditions and cancer.

Website:

www.metabolon.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Discovery Tools (Healthcare)
Laboratory Services (Healthcare)

Primary Office

Post Office Box 110407 Research Triangle Park Durham, NC 27709United States +1 (919) 572-1711
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Metabolon's full profile, request a free trial.

Metabolon Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Metabolon Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Metabolon Investors (14)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
180 Degree CapitalVenture CapitalMinority000 0000000 0000
Alexandria Venture InvestmentsVenture CapitalMinority000 0000000 0000
ATEL VenturesCorporate Venture CapitalMinority000 0000000 0000
Camden PartnersGrowth/ExpansionMinority000 0000000 0000
Crossroads CapitalLender/Debt ProviderMinority000 0000000 0000
180 Degree Capital Venture Capital
Alexandria Venture Investments Venture Capital
ATEL Ventures Corporate Venture Capital
Camden Partners Growth/Expansion
Crossroads Capital Lender/Debt Provider

Metabolon Executive Team (15)

NameTitleBoard
Seat
Contact
Info
John Ryals Ph.DPresident, Chief Executive Officer & Board Member
Steven Watkins Ph.DChief Technology Officer
Jay TolleyVice President & General Manager, Metabolomics & Biomarker Services
Lisa MillerVice President & General Manager, Precision Medicine
Michael Milburn Ph.DChief Scientific Officer
John Ryals Ph.D President, Chief Executive Officer & Board Member
Steven Watkins Ph.D Chief Technology Officer
Jay Tolley Vice President & General Manager, Metabolomics & Biomarker Services
Lisa Miller Vice President & General Manager, Precision Medicine
Michael Milburn Ph.D Chief Scientific Officer

Metabolon Board Members (10)

NameRepresentingRoleSinceContact
Info
Christopher Kersey MDCamden PartnersPartner & Managing Member000 0000
David PiersonMetabolonBoard Member000 0000
Guy Fish MDFletcher Spaght VenturesSenior Vice President000 0000
Jefferson ClarkThe Aurora FundsCo-Founder & Managing General Partner000 0000
John FletcherFletcher Spaght VenturesFounding Partner & Chief Executive Officer000 0000
Christopher Kersey MD Partner & Managing Member Camden Partners
David Pierson Board Member Metabolon
Guy Fish MD Senior Vice President Fletcher Spaght Ventures
Jefferson Clark Co-Founder & Managing General Partner The Aurora Funds
John Fletcher Founding Partner & Chief Executive Officer Fletcher Spaght Ventures
Request full access to PitchBook